![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Lower Ribavirin Exposures in HIV+ Patients that
Relapsed to Acute HCV Treatment: SWIFT-C
|
|
|
Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
Christine E. MacBrayne1, Michael D. Hughes2, Kimberly M. Hollabaugh2, JhoannaC. Roa3, Xinhui Chen1, Diana M. Brainard4, Raymond T. Chung5, Susanna Naggie6, Jennifer J. Kiser1and the A5327 Study Team
1University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, 2Harvard T.H. Chan School of Public Health, Boston, MA, 3Social and Scientific Systems, Silver Spring, MD, 4Gilead Sciences, Foster City, CA, 5Massachusetts General Hospital, Boston, MA, 6Duke Clinical Research Institute, Durham, NC
WEBCAST:http://www.croiwebcasts.org/console/player/29625?mediaType=audio&
![CROI1](../images/032316/032316-6/CROI1.gif)
![CROI2](../images/032316/032316-6/CROI2.gif)
![CROI3](../images/032316/032316-6/CROI3.gif)
![CROI4](../images/032316/032316-6/CROI4.gif)
![CROI5](../images/032316/032316-6/CROI5.gif)
![CROI6](../images/032316/032316-6/CROI6.gif)
![CROI7](../images/032316/032316-6/CROI7.gif)
![CROI8](../images/032316/032316-6/CROI8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|